CLINICAL TRIALS PROFILE FOR VOCLOSPORIN
✉ Email this page to a colleague
All Clinical Trials for voclosporin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00244842 ↗ | Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis | Completed | Aurinia Pharmaceuticals Inc. | Phase 3 | 2004-12-01 | The purpose of this study is to determine which dose of voclosporin is effective in the treatment of plaque psoriasis compared to placebo. |
NCT00258713 ↗ | A 36-Week Extension to Protocol ISA04-03 | Completed | Aurinia Pharmaceuticals Inc. | Phase 3 | 2005-09-01 | The purpose of this study is to determine the safety and efficacy of voclosporin in patients with plaque psoriasis. |
NCT00270634 ↗ | Study of ISA247 (Voclosporin) in De Novo Renal Transplantation | Completed | Aurinia Pharmaceuticals Inc. | Phase 2 | 2006-01-01 | This study will see if voclosporin is safe and effective in preventing kidney transplant rejection. |
NCT00408187 ↗ | Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients | Completed | Aurinia Pharmaceuticals Inc. | Phase 3 | 2006-12-01 | The purpose of this study is to determine the safety and efficacy of voclosporin in patients with plaque psoriasis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for voclosporin
Condition Name
Clinical Trial Locations for voclosporin
Trials by Country
Clinical Trial Progress for voclosporin
Clinical Trial Phase
Clinical Trial Sponsors for voclosporin
Sponsor Name